This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More
Protalix BioTherapeutics Inc
PLX : AMEX : Health Care
$2.08 -0.01 | -0.48%
Today's Range: 2.00 - 2.09
Avg. Daily Volume: 462,300
11/24/14 - 3:04 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
PLX PROTALIX BIOTHERAPEUTICS INC 2.11 197.65 n/m 14.55 16.68
BSTC BIOSPECIFICS TECHNOLOGIES CP 38.95 253.21 60.86 13.50 -2.91
CUR NEURALSTEM INC 2.80 244.61 n/m 0.02 -85.59
RTRX RETROPHIN INC 8.74 233.36 n/m 14.12 n/a
GALE GALENA BIOPHARMA INC 1.86 225.91 n/m 7.44 535.98
IDRA IDERA PHARMACEUTICALS INC 2.50 214.53 n/m 0.08 38.88
THLD THRESHOLD PHARMACEUTICALS 3.09 193.90 n/m 14.25 26.08
ENZY ENZYMOTEC LTD 8.57 189.52 18.63 54.83 208.84
STML STEMLINE THERAPEUTICS INC 14.07 186.88 n/m 0.29 n/a
AGEN AGENUS INC 2.97 186.17 n/m 5.75 53.62
NAVB NAVIDEA BIOPHARMACEUTICALS 1.21 182.40 n/m 4.61 664.67
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

PLX Ind Avg S&P 500
n/m 64.35 19.91
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs